Vanguard Personalized Indexing Management
LEGN icon

Vanguard Personalized Indexing Management’s Legend Biotech LEGN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,345
Closed -$240K – 2026
2025
Q3 		$240K Buy
7,345
+1,177
+19% +$43.5K ﹤0.01% 1604
2025
Q2 		$219K Buy
+6,168
New +$200K ﹤0.01% 1587
2024
Q4 		– Sell
-7,392
Closed -$360K – 1847
2024
Q3 		$360K Buy
7,392
+852
+13% +$45.4K 0.01% 1262
2024
Q2 		$290K Buy
6,540
+1,571
+32% +$72.5K 0.01% 1289
2024
Q1 		$279K Buy
4,969
+85
+2% +$5.13K 0.01% 1295
2023
Q4 		$294K Buy
4,884
+253
+5% +$16K 0.01% 1237
2023
Q3 		$311K Sell
4,631
-468
-9% -$32.5K 0.01% 1109
2023
Q2 		$352K Buy
5,099
+463
+10% +$30.3K 0.01% 1047
2023
Q1 		$224K Sell
4,636
-356
-7% -$17.4K 0.01% 1274
2022
Q4 		$249K Buy
+4,992
New +$242K 0.01% 1046
2022
Q3 		– Sell
-5,514
Closed -$303K – 1268
2022
Q2 		$303K Buy
+5,514
New +$233K 0.01% 987

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Personalized Indexing Management's LEGN Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 7,345 shares — an estimated $240K sold.

Vanguard Personalized Indexing Management first reported a position in LEGN in Q2 2022 and held it in 11 quarters. The position peaked at $360K in Q3 2024. 200 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 7,345 Legend Biotech shares in Q4 2025, an estimated $240K.
  • Vanguard Personalized Indexing Management first reported a position in Legend Biotech in Q2 2022 and held it in 11 quarters.
  • Vanguard Personalized Indexing Management's Legend Biotech position peaked at $360K in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.